Emotional control in selected somatic and psychiatric diseases.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
03 11 2023
Historique:
received: 01 06 2023
accepted: 29 10 2023
medline: 6 11 2023
pubmed: 4 11 2023
entrez: 4 11 2023
Statut: epublish

Résumé

was to assess the level of subjective control of emotional states among patients treated for dermatological and gastrointestinal somatic diseases compared to those with depressive and anxiety disorders. The results were related to the analyzed dimensions of emotion regulation in healthy subjects. The reports of the conducted studies were compiled for a total of 310 people, including 120 patients diagnosed with a somatic disease (psoriasis, rosacea, irritable bowel syndrome, and gastroesophageal reflux), as well as 96 patients diagnosed with depressive disorders and 30 patients with anxiety disorders. The control group consisted of healthy subjects (64 individuals). To assess the psychological variables analyzed, the subjects completed the Emotion Regulation Questionnaire developed by J. Brzeziński. The study showed that the patients suffering from a chronic somatic symptom disorder, similarly to those treated for depression and anxiety disorders, differed from the healthy individuals in most aspects of emotional control. The patients with dermatological and gastrointestinal diseases differed statistically significantly from the patients with depression and the patients with anxiety disorders in relation to three dimensions of emotional control. Patients with a somatic disease are characterized by higher emotional and rational motivation, lower emotional resilience and lower emotional arousal. A chronic disease co-occurs with the emotional sphere of a person's daily functioning. Regardless of the diagnosis in terms of somatic disorders and mental illnesses, the way in which emotional states are controlled can be an important factor in the onset of the disease, coping with it as well as the treatment process.

Identifiants

pubmed: 37924065
doi: 10.1186/s12888-023-05321-7
pii: 10.1186/s12888-023-05321-7
pmc: PMC10623861
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

802

Informations de copyright

© 2023. The Author(s).

Références

Int J Psychiatry Med. 2007;37(3):245-55
pubmed: 18314852
PLoS One. 2016 Mar 03;11(3):e0148373
pubmed: 26938215
J Eur Acad Dermatol Venereol. 2010 Apr;24(4):429-33
pubmed: 19744257
PLoS One. 2015 Mar 23;10(3):e0119500
pubmed: 25798822
Behav Res Ther. 2006 Apr;44(4):585-99
pubmed: 15998508
Compr Psychiatry. 2020 Oct;102:152189
pubmed: 32629064
Res Theory Nurs Pract. 2017 Aug 1;31(3):247-271
pubmed: 28793948
Georgian Med News. 2020 Apr;(301):143-147
pubmed: 32535579
J Am Osteopath Assoc. 2006 May;106(5 Suppl 2):S9-14
pubmed: 16738013
J Clin Med. 2022 Aug 30;11(17):
pubmed: 36079040
J Pers. 2008 Jun;76(3):561-80
pubmed: 18399953
J Affect Disord. 2017 Jun;215:111-117
pubmed: 28319687
Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
Psychoneuroendocrinology. 2005 Nov;30(10):947-52
pubmed: 15949897
Am J Geriatr Psychiatry. 2010 Jan;18(1):51-6
pubmed: 20094018
Dermatol Clin. 2005 Oct;23(4):657-64
pubmed: 16112442
J Affect Disord. 2012 Dec 10;141(2-3):474-9
pubmed: 22483953
World J Psychiatry. 2015 Dec 22;5(4):366-78
pubmed: 26740928
Neuropsychobiology. 2020;79(4-5):270-283
pubmed: 31340207
Psychosom Med. 2020 Apr;82(3):287-295
pubmed: 32058461
Biopsychosoc Med. 2007 Mar 01;1:5
pubmed: 17371575
Psychophysiology. 2002 May;39(3):281-91
pubmed: 12212647
Psychoneuroendocrinology. 2017 Apr;78:93-96
pubmed: 28183031
Dis Esophagus. 2002;15(3):199-203
pubmed: 12444990
Psychol Bull. 2017 Sep;143(9):939-991
pubmed: 28616996
Neuron. 2014 Jun 18;82(6):1205-8
pubmed: 24945765
J Pers. 2004 Dec;72(6):1301-33
pubmed: 15509284
J Anxiety Disord. 2008;22(2):211-21
pubmed: 17349775
Biol Psychiatry. 2008 Mar 15;63(6):577-86
pubmed: 17888411
Ind Psychiatry J. 2015 Jul-Dec;24(2):125-8
pubmed: 27212814

Auteurs

Agata Orzechowska (A)

Department of Adult Psychiatry, Medical University of Lodz, Lodz, 91-229, Poland.

Paulina Maruszewska (P)

Department of Adult Psychiatry, Medical University of Lodz, Lodz, 91-229, Poland.

Małgorzata Gałecka (M)

Department of Psychotherapy, Medical University of Lodz, Lodz, 91-229, Poland.

Philip Hyland (P)

Department of Psychology, Maynooth University, Maynooth, Co. Kildare, Ireland.

Daniel Boduszek (D)

Faculty of Psychology, SWPS University, Wrocław, 53-238, Poland.
Department of Psychology, University of Huddersfield, Huddersfield, HD1 3DH, UK.

Piotr Gałecki (P)

Department of Adult Psychiatry, Medical University of Lodz, Lodz, 91-229, Poland.

Katarzyna Bliźniewska-Kowalska (K)

Department of Adult Psychiatry, Medical University of Lodz, Lodz, 91-229, Poland. katarzyna.blizniewska-kowalska@umed.lodz.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH